Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Jan 25 EFFECT Notice of effectiveness
- 10 Jan 25 POS AM Prospectus update (post-effective amendment)
- 2 Oct 24 EFFECT Notice of effectiveness
- 1 Oct 24 424B7 Prospectus with selling stockholder info
- 20 Sep 24 S-1/A IPO registration (amended)
- 9 Sep 24 S-1/A IPO registration (amended)
-
2 Aug 24 S-1 IPO registration
RNAC similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Auditor
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of Cartesian Therapeutics, Inc. (formerly known as Selecta Biosciences, Inc.) of our report dated January 23, 2024, relating to the financial statements of Cartesian Therapeutics, Inc., which is contained in that Prospectus.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
| /s/ BDO USA, P.C. | |
Potomac, Maryland |